Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Colan Totte Co's revenue for the
three
months ended in Mar. 2026 was 円1,823 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was 円8,019 Mil.
Colan Totte Co's Revenue per Share for the
three
months ended in Mar. 2026 was 円199.76.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円878.65.
During the past 12 months, the average Revenue per Share Growth Rate of Colan Totte Co was 27.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 14.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 15.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 7 years, Colan Totte Co's highest 3-Year average Revenue per Share Growth Rate was 17.90% per year. The lowest was 13.80% per year. And the median was 14.30% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Colan Totte Co Revenue Related Terms
Colan Totte Co Revenue Historical Data
* Premium members only.
The historical data trend for Colan Totte Co's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Colan Totte Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Colan Totte Co Revenue vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Colan Totte Co's Revenue distribution charts can be found below:
* The bar in red indicates where Colan Totte Co's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円8,019 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Colan Totte Co (TSE:7792) has a Revenue of 円8,019 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Colan Totte Co and its competitors.
Is Colan Totte Co's Revenue too high?
Colan Totte Co's current Revenue is 円8,019 Mil. Overall, Colan Totte Co has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Colan Totte Co's Revenue compare to ABT and SYK?
Colan Totte Co's Revenue of 円8,019 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Colan Totte Co and its competitors. Colan Totte Co's current Revenue is 円8,019 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Colan Totte Co stock overvalued right now?
Based on GuruFocus' analysis, Colan Totte Co (TSE:7792) is currently considered Fairly Valued. The stock's GF Value™ is 円1,555.85, compared to a current price of 円1,512.00 — trading 2.8% below its estimated fair value. The current Revenue is 円8,019 Mil. Colan Totte Co's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Colan Totte Co (TSE:7792), the current Revenue is 円8,019 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Colan Totte Co (TSE:7792) Overvalued in 2026?
Based on GuruFocus' analysis, Colan Totte Co stock appears to be undervalued.
The current stock price of 円1,512.00 is trading 2.8% below its estimated GF Value™ of 円1,555.85.
GuruFocus considers Colan Totte Co to be Fairly Valued.
Key valuation signals for TSE:7792:
Revenue: 円8,019 Mil
GF Value™: 円1,555.85 vs. price of 円1,512.00 (2.8% below fair value)
No single metric tells the full story. See the TSE:7792 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Colan Totte Co Ltd is engaged in the manufacturing and sales of medical devices and health products. It divides its business into two segments: Colantotte Business is the brand that develops home magnetic therapy devices, which are the core of the company; and CSS Business is a service that connects people with their families, realizing contacting designated emergency contacts based on the desire to protect loved ones.
93GF Score
Get the complete analysis for TSE:7792
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7792 has been successfully added to your 
